Table 5. Impact of including rates of pre-treatment loss to follow-up on national tuberculosis programme indicators in hypothetical programmes in Africa and Asia with 100 000 individuals and DOTS strategy targets (70% case detection, 85% cure) theoretically achieved, 2011.
Indicator | Africa |
Asia |
|||
---|---|---|---|---|---|
Outcomes reported under current WHO targets | After including tuberculosis patients lost to follow-up before treatment | Outcomes reported under current WHO targets | After including tuberculosis patients lost to follow-up before treatment | ||
No. of cases | 100 000 | 100 000 | 100 000 | 100 000 | |
Cases detected, no. (%) | 70 000 (70) | 85 366a (85) | 70 000 (70) | 80 460a (80) | |
Tuberculosis patients lost to follow-up before treatment, no. (%) | Unknown | 15 366 (18) | Unknown | 10 460 (13) | |
Cases started on treatment, no. (%) | Unknown | 70 000 (82)b | Unknown | 70 000 (87)b | |
Patients cured, no. (%) | 59 500 (85) | 59 500 (70)c | 59 500 (85) | 59 500 (74)c | |
Deceased tuberculosis patients, no. (%) | 4200d (6) | 12 498e (12) | 2100d (3) | 3251e (3) |
WHO, World Health Organization.
a Calculated as [1 ÷ (1 − fraction lost to follow-up before treatment)] × number of cases detected. For Africa: [1 ÷ 0.82] × 70 000; for Asia: [1 ÷ 0.87] × 70 000.
b Percentage calculated as number of cases initiating tuberculosis treatment divided by the number of cases detected. For Africa: 70 000 ÷ 85 366; for Asia: 70 000 ÷ 80 460.
c Percentage calculated as the number of patients who successfully completed treatment divided by the number of cases detected. For Africa: 59 500 ÷ 85 366; for Asia: 59 500 ÷ 80 460.
d Number obtained from WHO country database.
e Calculated as the number of deceased tuberculosis patients plus the product of the number of cases lost to follow-up before treatment and the median case fatality rate found in this review. For Africa: 4200 + (15 366 × 0.54); for Asia: 2100 + (10 460 × 0.11).
Note: Estimates for the western Pacific region not included, as only one study was identified.